HY-130571-100mg
|
MedChemexpress LLC
|
m-PEG9-Amine [CAS 211859-73-3]
|
|
Cancer-programmed cell death
|
|
HY-130571-250mg
|
MedChemexpress LLC
|
m-PEG9-Amine [CAS 211859-73-3]
|
|
Cancer-programmed cell death
|
|
HY-130571-50mg
|
MedChemexpress LLC
|
m-PEG9-Amine [CAS 211859-73-3]
|
|
Cancer-programmed cell death
|
|
HY-132161-1mg
|
MedChemexpress LLC
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT [CAS 2378428-19-2]
|
|
Cancer-programmed cell death
|
|
HY-132161-5mg
|
MedChemexpress LLC
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT [CAS 2378428-19-2]
|
|
Cancer-programmed cell death
|
|
HY-P99746-1mg
|
MedChemexpress LLC
|
Mu rlentamab [CAS 2058047-65-5]
|
|
|
|
HY-P99746-10mg
|
MedChemexpress LLC
|
Mu rlentamab [CAS 2058047-65-5]
|
|
|
|
HY-P99746-5mg
|
MedChemexpress LLC
|
Mu rlentamab [CAS 2058047-65-5]
|
|
|
|
HY-P99152-1mg
|
MedChemexpress LLC
|
Mu romonab [CAS 140608-64-6]
|
|
COVID-19-immunoregulation
|
|
HY-P99152-10mg
|
MedChemexpress LLC
|
Mu romonab [CAS 140608-64-6]
|
|
COVID-19-immunoregulation
|
|
HY-P99152-5mg
|
MedChemexpress LLC
|
Mu romonab [CAS 140608-64-6]
|
|
COVID-19-immunoregulation
|
|
HY-B0199-1g
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-100mg
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-200mg
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-5g
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5]
|
|
Cancer-programmed cell death
|
|
HY-B0199-1mL
|
MedChemexpress LLC
|
Mycophenolate Mofetil [CAS 128794-94-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-130818-1g
|
MedChemexpress LLC
|
N-(5-Hydroxypentyl)maleimide [CAS 180608-78-0]
|
|
Cancer-programmed cell death
|
|
HY-130818-100mg
|
MedChemexpress LLC
|
N-(5-Hydroxypentyl)maleimide [CAS 180608-78-0]
|
|
Cancer-programmed cell death
|
|
HY-130818-500mg
|
MedChemexpress LLC
|
N-(5-Hydroxypentyl)maleimide [CAS 180608-78-0]
|
|
Cancer-programmed cell death
|
|
HY-126520-10mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126520-100mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126520-25mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126520-50mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126521-100mg
|
MedChemexpress LLC
|
N3-C3-NHS ester [CAS 943858-70-6]
|
|
Cancer-programmed cell death
|
|
HY-126521-500mg
|
MedChemexpress LLC
|
N3-C3-NHS ester [CAS 943858-70-6]
|
|
Cancer-programmed cell death
|
|